Notice: Images are for illustration only and may not reflect the exact product you receive. Brand-name medications may look different depending on their country of origin—Canadian versions, for example, often include a "PR" symbol on the packaging. Rest assured, the medication, dosage, and active ingredients will be exactly as prescribed. Canada Pharmacy Store is committed to your health and safety, and we work only with licensed pharmacies to ensure you receive trusted, high-quality medication every time.
General Medication Fact Sheet for Glyxambi
| Field | Information |
|---|---|
| Medication Name | Glyxambi |
| Generic Name | Empagliflozin/Linagliptin |
| Purpose | Used to treat type 2 diabetes mellitus, improving blood sugar control |
| Mechanism of Action | Empagliflozin: SGLT2 inhibitor, reducing glucose reabsorption in kidneys. Linagliptin: DPP-4 inhibitor, increasing incretin levels and insulin release. |
| Dosage Forms | Oral tablets |
| Available Strengths | 10 mg/5 mg, 25 mg/5 mg (Empagliflozin/Linagliptin) |
| Dosage Frequency | Once daily |
| Common Side Effects | Urinary tract infections, nasopharyngitis (common cold), increased urination, upper respiratory tract infection |
| Serious Side Effects | Ketoacidosis, kidney problems, pancreatitis, hypoglycemia (especially if used with insulin or sulfonylureas) |
| Drug Interactions | Insulin, sulfonylureas, diuretics, rifampin, other diabetes medications |
| Important Notes | Not for type 1 diabetes or diabetic ketoacidosis; maintain adequate hydration; monitor kidney function. |
| Storage | Store at room temperature away from moisture and light |
| Missed Dose | Take as soon as you remember unless it is almost time for your next dose. Do not double the dose. |
| Alternatives | Metformin, Jardiance (empagliflozin), Tradjenta (linagliptin), Januvia (sitagliptin) |
Glyxambi Alternatives
| Medication | Mechanism of Action | Notes |
|---|---|---|
| Metformin | Decreases hepatic glucose production and increases insulin sensitivity. | First-line treatment for type 2 diabetes. |
| Jardiance (empagliflozin) | SGLT2 inhibitor, reduces glucose reabsorption in the kidneys. | Monotherapy SGLT2 inhibitor. |
| Tradjenta (linagliptin) | DPP-4 inhibitor, increases incretin levels and insulin release. | Monotherapy DPP-4 inhibitor. |
| Januvia (sitagliptin) | DPP-4 inhibitor, increases incretin levels and insulin release. | Another DPP-4 inhibitor with similar effects to linagliptin. |
Glyxambi Side Effects
| Common Side Effects | Serious Side Effects |
|---|---|
| Urinary tract infections | Ketoacidosis |
| Nasopharyngitis (common cold) | Kidney problems |
| Increased urination | Pancreatitis |
| Upper respiratory tract infection | Hypoglycemia (especially with insulin or sulfonylureas) |
| Genital yeast infections | Severe allergic reactions (rare) |
Glyxambi Dosage Guide
| Condition | Starting Dose | Maintenance Dose | Administration Notes |
|---|---|---|---|
| Type 2 Diabetes | 10 mg/5 mg once daily | 10 mg/5 mg or 25 mg/5 mg once daily | Take once daily, preferably in the morning. |
Glyxambi Price With And Without Insurance
| Purchase Context | Estimated Price |
|---|---|
| With Insurance | $25 |
| Without Insurance (U.S.) | $650 |
| From CPS | $319 |
